Pages

▼
Friday, November 5, 2021

Molnupiravir may become the first COVID-19 pill. What took so long?

›
By Lisa Larrimore Ouellette , Nicholson Price , Rachel Sachs , and Jacob S. Sherkow On October 1, the developers of the COVID-19 antiviral m...
Sunday, October 10, 2021

Courtney Cox on Trade Secrets and Lying

›
Courtney Cox, a professor at Fordham University Law School, has a very interesting trade secret law article forthcoming in George Washington...
Monday, September 27, 2021

How would the proposed American Pandemic Preparedness Plan help address underinvestment in pandemic-related innovation?

›
By Jacob S. Sherkow , Lisa Larrimore Ouellette , Nicholson Price , and Rachel Sachs Historically, the United States’ preparedness for a pand...
Friday, August 27, 2021

How does the CDC’s Advisory Committee on Immunization Practices impact innovation and access to COVID-19 vaccines?

›
By Rachel Sachs , Jacob S. Sherkow , Lisa Larrimore Ouellette , and Nicholson Price In previous blog posts in this series, we have explored ...
Friday, July 30, 2021

What’s happening with proposals for a WTO waiver of COVID-related IP?

›
By Nicholson Price , Rachel Sachs , Jacob S. Sherkow , and Lisa Larrimore Ouellette If COVID-19 were a pandemic movie , we’d be very close t...
Monday, July 12, 2021

New Free Patent Casebook by Masur & Ouellette

›
As previously announced , I have been writing a new free patent law casebook with Prof. Jonathan Masur (Chicago Law), and we're very gra...
Thursday, July 1, 2021

Rob Merges Guest Post: Who Gives a Hoot About Minerva? The Patent Act and the Common Law of Patents

›
Guest Post by Rob Merges , UC Berkeley In the immediate, practical sense, the Minerva opinion registers like the mildest tremor on the land...
Wednesday, June 30, 2021

Why do differences in clinical trial design make it hard to compare COVID-19 vaccines?

›
By Lisa Larrimore Ouellette , Nicholson Price , Rachel Sachs , and Jacob S. Sherkow The number of COVID-19 vaccines is growing , with 18 vac...
Friday, June 4, 2021

What Does it Mean to Exceed Authorized Access?

›
After years of debate and prosecutorial overreach, the Supreme Court has now narrowed the Computer Fraud and Abuse Act (CFAA). In Van Buren ...
Thursday, June 3, 2021

What’s the difference between vaccine approval (BLA) and authorization (EUA)?

›
By Jacob S. Sherkow , Lisa Larrimore Ouellette , Nicholson Price , and Rachel Sachs Recently, Pfizer and BioNTech and Moderna announced th...
Monday, May 17, 2021

Guy Rub: Copyright or Contract?

›
Using software often means you have to sign a contract as a condition for using the software. This "end user license agreement," c...
Monday, May 3, 2021

What can policymakers learn from the UK’s RECOVERY trial to improve clinical research for COVID-19 and beyond?

›
By Rachel Sachs , Jacob S. Sherkow , Lisa Larrimore Ouellette , and Nicholson Price We have written before about the challenges of making de...
Friday, April 9, 2021

How can Congress create infrastructure for the next pandemic?

›
By Nicholson Price , Rachel Sachs , Jacob S. Sherkow , and Lisa Larrimore Ouellette After approximately 200 Infrastructure Weeks , policymak...
Tuesday, April 6, 2021

Google v. Oracle - The Final Shoe Drops

›
The Supreme Court ruled yesterday in Google v. Oracle that Google did not infringe Oracle's copyright in its APIs by virtue of fair use...
Thursday, March 25, 2021

How are COVID-19 vaccine developers and regulators responding to variants?

›
By Lisa Larrimore Ouellette , Nicholson Price , Rachel Sachs , and Jacob S. Sherkow The remarkable news of record-breaking COVID-19 vaccine ...